Endothelial Dysfunction Therapeutics Clinical Trials Market Review H1 2015 Available at RnRMarketResearch.com

News provided by

RnR Market Research

Apr 08, 2015, 10:30 ET

Dallas, Texas (PRWEB) April 08, 2015 -- The report “Endothelial Dysfunction Global Clinical Trials Review, H1, 2015” provides elemental information and data relating to the clinical trials on Endothelial Dysfunction. Endothelial dysfunction is characterized by a disturbed endothelium-dependent vasodilation and decreased bioavailability of nitric oxide. It has been observed in several diseases and has been widely studied as it is often an early disease event in these. Endothelial dysfunction is associated with a number of cardiovascular diseases. The capacity of peripheral vessels to respond adequately to shear stress and to dilate during exercise is one of the main determinants of exercise capacity in patients with chronic heart failure. Complete report with TOC is available at http://www.rnrmarketresearch.com/endothelial-dysfunction-global-clinical-trials-review-h1-2015-market-report.html .

Companies discussed in this Endothelial Dysfunction Global Clinical Trials Review, H1, 2015 report include Novartis AG, Pfizer Inc., BioMarin Pharmaceutical Inc., Takeda Pharmaceutical Company Limited, Sanofi, Nestle S.A., Gilead Sciences, Inc. and C. H. Boehringer Sohn AG & Co. KG.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Order a purchase copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=348920 . (This is a premium report priced at US$2500 for a single user License.)

List of Tables
Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Region, 2015* 7
Endothelial Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Endothelial Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Endothelial Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Endothelial Dysfunction Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Endothelial Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Endothelial Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15
Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18
Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Endothelial Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Endothelial Dysfunction Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Endothelial Dysfunction Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Endothelial Dysfunction Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Endothelial Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Endothelial Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Endothelial Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Endothelial Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Endothelial Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

List of Figures
Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Endothelial Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Endothelial Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Endothelial Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Endothelial Dysfunction Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Endothelial Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Endothelial Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15
Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Explore more reports on Clinical Trial industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/clinical-trial .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Ritesh Tiwari, RnR Market Research, http://www.rnrmarketresearch.com/, +1 (888) 391-5441, [email protected]